Mainz Biomed (MYNZ) Return on Sales (2022 - 2025)
Historic Return on Sales for Mainz Biomed (MYNZ) over the last 4 years, with Q2 2025 value amounting to 24.14%.
- Mainz Biomed's Return on Sales rose 64400.0% to 24.14% in Q2 2025 from the same period last year, while for Jun 2025 it was 24.14%, marking a year-over-year increase of 64400.0%. This contributed to the annual value of 24.22% for FY2024, which is 51500.0% up from last year.
- Mainz Biomed's Return on Sales amounted to 24.14% in Q2 2025, which was up 64400.0% from 28.97% recorded in Q4 2024.
- In the past 5 years, Mainz Biomed's Return on Sales ranged from a high of 24.14% in Q4 2023 and a low of 57.82% during Q3 2022
- Over the past 4 years, Mainz Biomed's median Return on Sales value was 33.15% (recorded in 2023), while the average stood at 37.11%.
- As far as peak fluctuations go, Mainz Biomed's Return on Sales soared by 300900bps in 2023, and later plummeted by -48300bps in 2024.
- Mainz Biomed's Return on Sales (Quarter) stood at 42.37% in 2022, then soared by 43bps to 24.14% in 2023, then fell by -20bps to 28.97% in 2024, then increased by 17bps to 24.14% in 2025.
- Its Return on Sales stands at 24.14% for Q2 2025, versus 28.97% for Q4 2024 and 30.58% for Q2 2024.